EU-funded Parkinson’s research project launched at University of Luxembourg

News

Author: Almaz OhenePublished: 9 December 2015

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

News image

The EU is funding a €5.9 million research project at the University of Luxembourg that aims to develop new techniques to identify active compounds for use in the treatment of Parkinson’s disease.

Researchers will concentrate on patterns of Parkinson’s disease in which the mitochondria – the part of the cell that takes in nutrients – are damaged by mutations in individual genes.

The project, Systems Medicine of Mitochondrial Parkinson’s Disease (SysMedPD), brings together partner institutions and pharmaceutical companies from across Europe such as Luxembourg, Germany, Ireland, the Netherlands and the UK.

Dr Ronan Fleming, LCSB scientist and SysMedPD coordinator, said: “We estimate that in about 10-20% of all Parkinson’s patients, their mitochondria do not function properly. In order to better diagnose, heal or at least effectively curb the progression of Parkinson’s disease, we must understand this dysfunction of mitochondria in detail.”

Go Back

Share this story

Comments


Related articles


Talking about Parkinson’s disease with young children has never been easy. But, here are five books to help you explain the condition in a more accessible way to the younger ones in your family

Resources & Tools

5 free books to help explain Parkinson’s to children and teens

How to talk to young children about Parkinson’s disease

READ MORE
Steve Sant CEO Parkinson’s Australia

In my country

Supporting 100,000 Australians with Parkinson’s

We spoke to the CEO of Parkinson’s Australia

READ MORE
a-neuronal-journey

Europe

Picturing Parkinson’s: scientists capture brain cells in striking detail

Amazing images show Parkinson’s brain cells in microscopic detail

READ MORE